Bay Colony Advisory Group, Inc D Novo Nordisk A S Transaction History
Bay Colony Advisory Group, Inc D
- $554 Million
- Q1 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Novo Nordisk A S stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 17,374 shares of NVO stock, worth $2.44 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
17,374
Previous 10,596
63.97%
Holding current value
$2.44 Million
Previous $1.1 Million
103.47%
% of portfolio
0.4%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,862Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.96 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.93 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.83 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.69 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.66 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $317B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...